Drug intelligence / Profile preview

Hemo Forte

Development stage: Unknown
Lead developer: Torque Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

Hemo Forte is a nutritional supplement syrup developed and marketed by Torque Pharmaceuticals in India. It is a combination product containing Iron (III)-Hydroxide Polymaltose Complex and Folic Acid. The iron polymaltose complex is a non-ionic formulation designed to provide 50 mg of elemental iron per dose with improved gastrointestinal tolerance and reduced metallic taste compared to conventional ferrous salts. Folic acid (0.5 mg) is included to support erythropoiesis and DNA synthesis. The product is primarily indicated for the prevention and treatment of iron deficiency anemia and folic acid deficiency, and it is available as an over-the-counter consumer healthcare product.

Brand names: Hemo Forte

Beyond the preview

Go deeper on Hemo Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemo Forte.

Explore the full profile